Related Content
- Mylan's Hyzaar, Cozaar generics receive OK from FDA
- New alliance will crack down on adulterated products touting dietary supplement claims
- FDA approves Novartis drug for high blood pressure treatment
- Mylan's generic Precose gets green light from FDA
- Merck's hepatitis C drug granted priority review by FDA
PITTSBURGH — The Food and Drug Administration has approved a generic drug made by Mylan that reduces pressure in the eye, Mylan said Monday.
Mylan announced the approval of latanoprost ophthalmic solution in the 0.005% strength. The drug is a generic version of Xalatan, made by Pharmacia and Upjohn, now part of Pfizer.
Various versions of the drug had sales of around $711 million in 2010, according to IMS Health.
